ALBEMARLE CORP News
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide, lithium chloride, and lithium specialties and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles, catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based products used in fire safety solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for surfactants, biocides, disinfectants, and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage, petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina.
see moreALBEMARLE CORP Market News
2d
No New Material Albemarle (ALB) Developments in Past Week as Q3 Earnings Window Opens
- Albemarle (ALB) saw no verified material news in the past week. Investors now turn attention to its upcoming Q3 2026 earnings announcement.
9d
Albemarle Confirms Q3 2026 Earnings Release Date Amid CEO Succession Transition
Albemarle (NYSE: ALB) will issue its third‑quarter 2026 earnings after market close on November 4, 2026, as CEO succession plans progress.
16d
Albemarle’s Stock Dips After CEO Succession Announcement as Udd Named to Lead
Albemarle shares declined around 1.7% following its September 3 announcement appointing Ragnar Udd as CEO, effective February 1, 2027, while Kent Masters shifts to executive chairman.
23d
No Major Albemarle (ALB) Developments Reported This Week Amid Ongoing Long‑Term Strategy
No significant new developments involving Albemarle emerged in the past week. The company’s most recent material updates remain the CEO succession plan and Q2 2026 earnings.
15 Sep at 21:39
Albemarle Appoints New CEO Succession Plan Effective February 2027
Albemarle announces CEO succession as Ragnar Udd will become President and CEO on Feb. 1, 2027, with Kent Masters transitioning to Executive Chairman.